Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis.

Autor: Jácome AA; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Castro ACG; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Vasconcelos JPS; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Silva MHCR; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Lessa MAO; Oncoclínicas, Salvador, Brazil., Moraes ED; Oncoclínicas, Salvador, Brazil., Andrade AC; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Lima FMT; Oncoclínicas, Rio de Janeiro, Brazil., Farias JPF; Oncoclínicas, Rio de Janeiro, Brazil., Gil RA; Oncoclínicas, Rio de Janeiro, Brazil., Prolla G; Oncoclínicas, Porto Alegre, Brazil., Garicochea B; Oncoclínicas, São Paulo, Brazil.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Dec 01; Vol. 4 (12), pp. e2136128. Date of Electronic Publication: 2021 Dec 01.